As of September 2024, XSpray Pharma AB has a market cap of $151.19M. This makes XSpray Pharma AB the world's 18928th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $120.95M | -0.50% |
2023 | $121.56M | -29.82% |
2022 | $173.22M | -11.08% |
2021 | $194.80M | -66.96% |
2020 | $589.55M | 133.17% |
2019 | $252.84M | 18.18% |
2018 | $213.94M | 13.09% |
2017 | $189.17M | - |